Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
106.20
+1.63 (1.56%)
At close: Oct 30, 2026, 4:00 PM EDT
105.90
-0.30 (-0.28%)
After-hours: Oct 30, 2026, 7:38 PM EDT
Abbott Laboratories Employees
Abbott Laboratories had 122,000 employees as of September 30, 2026. The number of employees increased by 7,000 or 6.09% compared to the same quarter last year. That makes Abbott Laboratories the 228th largest employer in the world and 72nd in the United States.
Employees
122,000
Change (1Y)
7,000
Growth (1Y)
6.09%
Revenue / Employee
$419,383
Profits / Employee
$40,670
Market Cap
183.77B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2026 | 122,000 | 7,000 | 6.09% |
| Dec 31, 2025 | 115,000 | 1,000 | 0.88% |
| Dec 31, 2024 | 114,000 | 0 | - |
| Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
| Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
| Dec 31, 2021 | 113,000 | 4,000 | 3.67% |
| Dec 31, 2020 | 109,000 | 2,000 | 1.87% |
| Dec 31, 2019 | 107,000 | 4,000 | 3.88% |
| Dec 31, 2018 | 103,000 | 4,000 | 4.04% |
| Dec 31, 2017 | 99,000 | 24,000 | 32.00% |
| Dec 31, 2016 | 75,000 | 1,000 | 1.35% |
| Dec 31, 2015 | 74,000 | -3,000 | -3.90% |
| Dec 31, 2014 | 77,000 | 8,000 | 11.59% |
| Dec 31, 2013 | 69,000 | -22,000 | -24.18% |
| Dec 31, 2012 | 91,000 | 0 | - |
| Dec 31, 2011 | 91,000 | 1,000 | 1.11% |
| Dec 31, 2010 | 90,000 | 17,000 | 23.29% |
| Dec 31, 2009 | 73,000 | 4,000 | 5.80% |
| Dec 31, 2008 | 69,000 | 1,000 | 1.47% |
| Dec 31, 2007 | 68,000 | 1,337 | 2.01% |
| Dec 31, 2006 | 66,663 | 6,928 | 11.60% |
| Dec 31, 2005 | 59,735 | -865 | -1.43% |
| Dec 31, 2004 | 60,600 | -11,600 | -16.07% |
| Dec 31, 2003 | 72,200 | 381 | 0.53% |
| Dec 31, 2002 | 71,819 | 393 | 0.55% |
| Dec 31, 2001 | 71,426 | 10,855 | 17.92% |
| Dec 31, 2000 | 60,571 | 3,471 | 6.08% |
| Dec 31, 1999 | 57,100 | 864 | 1.54% |
| Dec 31, 1998 | 56,236 | 1,749 | 3.21% |
| Dec 31, 1997 | 54,487 | 1,670 | 3.16% |
| Dec 31, 1996 | 52,817 | 2,576 | 5.13% |
| Dec 31, 1995 | 50,241 | 777 | 1.57% |
| Dec 31, 1994 | 49,464 | -195 | -0.39% |
| Dec 31, 1993 | 49,659 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Medtronic | 95,000 |
| Koninklijke Philips | 63,670 |
| Boston Scientific | 59,000 |
| Stryker | 56,000 |
| GE HealthCare Technologies | 54,000 |
| STERIS | 17,937 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
ABT News
- 19 hours ago - FDA posts adverse event report for Abbott’s Tendril SDX - TheFly
- 2 days ago - Abbott initiates pivotal trial for Cephea device - TheFly
- 2 days ago - Abbott initiates pivotal trial for Cephea™ device, an innovative treatment for mitral heart valve disease - PRNewsWire
- 4 days ago - Abbott cut to Hold at Argus amid reimbursement uncertainty, competitive pressure - TheFly
- 4 days ago - Abbott downgraded to Hold from Buy at Argus - TheFly
- 5 days ago - Abbott announces commercial availability of Oncodetect residual disease test - TheFly
- 5 days ago - Abbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatment - PRNewsWire
- 8 days ago - Abbott presents data from Oncodetect MRD study - TheFly